Edap Tms SA
NASDAQ:EDAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Edap Tms SA
Free Cash Flow
Edap Tms SA
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Free Cash Flow
-€16.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-20%
|
|
|
Biomerieux SA
PAR:BIM
|
Free Cash Flow
€453.1m
|
CAGR 3-Years
34%
|
CAGR 5-Years
8%
|
CAGR 10-Years
16%
|
|
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
Free Cash Flow
€3.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Free Cash Flow
-€3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Free Cash Flow
-€12.8m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mauna Kea Technologies SA
PAR:ALMKT
|
Free Cash Flow
-€5m
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
|
Edap Tms SA
Glance View
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.
See Also
What is Edap Tms SA's Free Cash Flow?
Free Cash Flow
-16.3m
EUR
Based on the financial report for Sep 30, 2025, Edap Tms SA's Free Cash Flow amounts to -16.3m EUR.
What is Edap Tms SA's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-20%
Over the last year, the Free Cash Flow growth was 54%.
